Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10055164 | 1.00 | GABRR1 (0.44) | GABRR1BCAT2APAF1CYP2D6CYP2C19 | |
| SCHEMBL10056838 | 1.00 | GABRR1 (0.44) | GABRR1BCAT2APAF1CYP2D6CYP2C19 | |
| Beta-Alanine SCHEMBL3708251 | 0.84 | GABRR1 (0.41) | GABRR1BCAT2APAF1CYP2D6CYP1A2 | |
| SCHEMBL16157279 | 0.83 | BCAT2 (0.39) | GABRR1BCAT2CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL24241859 | 0.82 | GABRR1 (0.41) | GABRR1APAF1CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL11808826 | 0.82 | GABRR1 (0.41) | GABRR1APAF1CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL18872073 | 0.82 | GABRR1 (0.41) | GABRR1APAF1CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL5499655 | 0.82 | BCAT2 (0.40) | GABRR1BCAT2CYP2D6CYP2C19 | |
| SCHEMBL18125961 | 0.80 | CYP2D6 (0.64) | GABRR1APAF1CYP2D6CYP2C19CYP1A2 | |
| SCHEMBL15044013 | 0.80 | CYP2D6 (0.64) | GABRR1APAF1CYP2D6CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118425362-B | Organic acid metabolism marker for distinguishing wild and cultivated four-big domestic fish and application thereof | 中国水产科学研究院长江水产研究所 | 2024-12-10 | — | — | CN | claimed |
| CN-118425362-A | Organic acid metabolism marker for distinguishing wild and cultivated four-big domestic fish and application thereof | 中国水产科学研究院长江水产研究所 | 2024-08-02 | — | — | CN | claimed |
| CN-116718697-A | Metabolite screening method for prolonging QTc interval of drug-resistant pulmonary tuberculosis and application | 首都医科大学附属北京胸科医院 | 2023-09-08 | — | — | CN | claimed |
| US-20230204605-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2023-06-29 | — | — | US | claimed |
| CN-111060607-A | Metabolite combination for pre-operation early warning of transplanted kidney delayed recovery after cardiac death and screening method thereof | 浙江大学 | 2020-04-24 | — | — | CN | claimed |
| CN-110716039-A | Application of metabolic marker in early diagnosis of AD and prediction of curative effect of sharpleaf galangal fruit on AD | 郑州大学第一附属医院 | 2020-01-21 | — | — | CN | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| EP-1374911-B1 | AGENTS FOR MEASURING PYRIMIDINE METABOLIZABILITY | OTSUKA PHARMA CO LTD (JP) | 2013-10-16 | — | — | EP | claimed |
| CN-101232905-B | Oral preparation useful in measuring capacity to metabolize pyridine | OTSUKA PHARMA CO LTD | 2013-01-09 | — | — | CN | claimed |
| EP-1579015-A2 | METHOD FOR PCR CLEANUP AND OLIGONUCLEOTIDE REMOVAL | Applera Corporation (US) | 2005-09-28 | — | — | EP | claimed |
| EP-1579015-A3 | METHOD FOR PCR CLEANUP AND OLIGONUCLEOTIDE REMOVAL | Applera Corporation (US) | 2005-08-25 | — | — | EP | claimed |
| US-20040234452-A1 | Composition for determining pyrimidine metabolizing activity | OTSUKA PHARMACEUTICAL CO., LTD. | 2004-11-25 | — | — | US | claimed |
| US-6797256-B2 | Composition for determining pyrimidine metabolizing activity | OTSUKA PHARMACEUTICAL CO. LTD. (JP) | 2004-09-28 | — | — | US | claimed |
| US-20040023220-A1 | Integrated method for PCR cleanup and oligonucleotide removal | APPLIED BIOSYSTEMS, LLC | 2004-02-05 | — | — | US | claimed |
| WO-2004009851-A2 | METHOD FOR PCR CLEANUP AND OLIGONUCLEOTIDE REMOVAL | APPLERA CORPORATION (US) | 2004-01-29 | — | — | WO | claimed |
| EP-1374911-A1 | AGENTS FOR MEASURING PYRIMIDINE METABOLIZABILITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-01-02 | — | — | EP | claimed |
| US-20030068272-A1 | Preparation for determining pyrimidine metabolic capacity | OTSUKA PHARMACEUTICAL CO., LTD. | 2003-04-10 | — | — | US | claimed |
| US-20020132283-A1 | Composition for determining pyrimidine metabolizing activity | OTSUKA PHARMACEUTICAL CO. LTD. (JP) | 2002-09-19 | — | — | US | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |